Changzheng hospital
Changzheng hospital
Shanghai, Shanghai Municipality, China5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 1 | 2026-07-23 | NCT06895811 | |
| Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP) | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate adenocarcinoma, prostate cancer, prostate disorder | Recruiting | Not applicable | 2026-07-23 | NCT06238713 | |
| Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Active, not recruiting | Early phase 1 | 2026-07-23 | NCT06228404 | |
| Safety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) | mCRPC | Not yet recruiting | Early phase 1 | 2026-02-05 | NCT07389187 | |
| Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate Cancer | Prostate Cancer Adenocarcinoma; mHNPC; mHSPC | Not yet recruiting | Early phase 1 | 2026-02-05 | NCT07389174 |